Firstly hello everyone.
I was given my active diagnosis of Relapsing MS in December, then there was mention of a trial, today I received an email with the details.
Info of the trial drug is on the https://www.mssociety.org.uk/ms-research/treatments-in-the-pipeline/ocrelizumab
My question to everyone is… Is it worth risking a trial when the alternative drug in the trial is a weak first line compared to the alternative known non trial drug?
My appointment is on Friday so responses would help please.
You must be logged in to reply to this topic.